GSK expects to deliver annual sales and profit growth towards the top end of its forecasts after beating second-quarter ...

British drugmaker GSK said on Wednesday it is in talks with the Trump administration about ways to lower U.S. drug costs, ...

Shares of GSK PLC GSK slid 3.04% to £14.18 Thursday, on what proved to be an all-around rough trading session for the stock ...

UK-listed pharmaceutical company plans to bring four more speciality medicines to late-stage clinical trials this year ...

British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, ...

Second-quarter sales rose to £7.99 billion from £7.88 billion in the same period the year prior.

GSK ( NYSE: GSK) CEO Emma Walmsley said on Wednesday that her company is in discussions with the Trump administration on how ...

GSK PLC GSK shares rose 4.69% to £14.63 Wednesday, on what proved to be an all-around favorable trading session for the stock ...

(Reuters) -British drugmaker GSK expects annual sales and profit to be towards the top of its forecast range, after ...

GSK said on Wednesday it expects to report annual sales and profit towards the top end of its forecast range, after the ...

GSK tops Q2 estimates with growth in vaccines and specialty drugs, raises 2025 forecast amid progress in major late-stage ...

As you might know, GSK plc (LON:GSK) recently reported its interim numbers. GSK reported UK£16b in revenue, roughly in line ...